CLU and Alzheimer disease: These correlative studies demonstrating that excess levels of clusterin are associated with more severe AD symptoms are supported by studies indicating that removing clusterin in mouse models of AD results in a reduced plaque load as well as improved performance on memory tasks [53–55].